p53-independent role of MDM2 in TGF-beta1 resistance (Q40987634)

25 September 2017

p53-independent role of MDM2 in TGF-beta1 resistance (English)

1 reference

25 September 2017

P Sun

1

1 reference

25 September 2017

P Dong

2

1 reference

25 September 2017

K Dai

3

1 reference

25 September 2017

G J Hannon

4

1 reference

25 September 2017

D Beach

5

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

25 September 2017

1 reference

25 September 2017

282

1 reference

25 September 2017

2270-2272

1 reference

25 September 2017

5397

1 reference

Smad3 mutant mice develop metastatic colorectal cancer

25 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Mdm-2: "big brother" of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Interaction between the retinoblastoma protein and the oncoprotein MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Transcriptional control by E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Aberrant responses of human lymphocytic neoplasms to cytokine regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Transforming growth factor-beta in breast cancer: a working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Overexpression of the MDM2 oncogene in leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.282.5397.2270

10.1126/SCIENCE.282.5397.2270

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference